Gene: NR0B1
Official Full Name: nuclear receptor subfamily 0 group B member 1provided by HGNC
Gene Summary: This gene encodes a protein that contains a DNA-binding domain. The encoded protein acts as a dominant-negative regulator of transcription which is mediated by the retinoic acid receptor. This protein also functions as an anti-testis gene by acting antagonistically to Sry. Mutations in this gene result in both X-linked congenital adrenal hypoplasia and hypogonadotropic hypogonadism. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO39062 | NR0B1 Knockout cell line (HEK293) | Human | NR0B1 | 1:3~1:6 | Negative | Online Inquiry |
KO39063 | NR0B1 Knockout cell line (A549) | Human | NR0B1 | 1:3~1:4 | Negative | Online Inquiry |
NR0B1 Gene Knockout Cell Lines represent a sophisticated tool for researchers studying the mechanisms underlying steroidogenic pathways and reproductive development. These cell lines are engineered using CRISPR-Cas9 technology to effectively disrupt the NR0B1 gene, which encodes a nuclear receptor essential for the regulation of steroid hormone production and crucial for normal gonadal development. By facilitating the functional analysis of this gene, these knockout cell lines allow scientists to delineate the molecular pathways involved in various endocrine disorders.
The principal mechanism of action of the NR0B1 knockout involves the complete abrogation of gene expression, allowing for the assessment of phenotypic changes and cellular responses in the absence of the NR0B1 protein. Researchers can utilize these models to investigate not only the role of NR0B1 in sex differentiation but also its implications in related conditions such as Turner Syndrome and adrenal insufficiency.
The scientific importance of NR0B1 knockout cell lines is profound; they provide a foundational platform for drug discovery, genetic studies, and the development of targeted therapies. By offering insights into gene function and regulatory networks, these tools can significantly enhance understanding of reproductive health and endocrinology, facilitating translational research that bridges basic sciences with clinical applications.
Compared to traditional animal models, NR0B1 knockout cell lines offer several advantages. They provide a more controlled environment, reduce variability in experimental outcomes, and lower ethical concerns associated with animal research. Their cost-effectiveness and ease of manipulation further make them a unique asset in the laboratory.
For researchers and clinicians focusing on hormone-related disorders or developmental biology, these cell lines not only streamline experimental workflows but also foster innovation in therapeutic development. Leveraging our extensive experience in genomic engineering, we ensure the highest quality and reliability of our NR0B1 Gene Knockout Cell Lines, empowering scientists to unlock new frontiers in biological research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.